Literature DB >> 23832121

Targeted cytolysins synergistically potentiate cytoplasmic delivery of gelonin immunotoxin.

Christopher M Pirie1, David V Liu, K Dane Wittrup.   

Abstract

Targeted endocytic uptake is a first step toward tissue-specific cytoplasmic macromolecular delivery; however, inefficient escape from the endolysosomal compartment makes this generally impractical at present. We report here a targeted cytolysin approach that dramatically potentiates endosomal release of an independently targeted potent gelonin immunotoxin. Fibronectin domains engineered for affinity to EGF receptor or carcinoembryonic antigen were fused to the plant toxin gelonin or bacterial pore-forming cytolysins. These fusion proteins display synergistic activity in both antigen-specific cytotoxicity in vitro, enhancing potency by several orders of magnitude, and in tumor growth inhibition in vivo. In addition, the number of internalized gelonin molecules required to induce apoptosis is reduced from approximately 5 × 10(6) to less than 10(3). Targeted potentiation shows promise for enhancing cytoplasmic delivery of other macromolecular payloads such as DNA, siRNA, and miRNA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832121      PMCID: PMC4030390          DOI: 10.1158/1535-7163.MCT-12-1023

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  39 in total

1.  Quantifying colocalization by correlation: the Pearson correlation coefficient is superior to the Mander's overlap coefficient.

Authors:  Jeremy Adler; Ingela Parmryd
Journal:  Cytometry A       Date:  2010-08       Impact factor: 4.355

Review 2.  Efficient and targeted delivery of siRNA in vivo.

Authors:  Min Suk Shim; Young Jik Kwon
Journal:  FEBS J       Date:  2010-12       Impact factor: 5.542

Review 3.  Ribosome-inactivating proteins up to date.

Authors:  F Stirpe; L Barbieri
Journal:  FEBS Lett       Date:  1986-01-20       Impact factor: 4.124

4.  Convergent potency of internalized gelonin immunotoxins across varied cell lines, antigens, and targeting moieties.

Authors:  Christopher M Pirie; Benjamin J Hackel; Michael G Rosenblum; K Dane Wittrup
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

5.  Tumor cell killing enabled by listeriolysin O-liposome-mediated delivery of the protein toxin gelonin.

Authors:  Chester J Provoda; Ethan M Stier; Kyung-Dall Lee
Journal:  J Biol Chem       Date:  2003-06-27       Impact factor: 5.157

6.  Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat.

Authors:  J S Barrett; J G Wagner; S J Fisher; R L Wahl
Journal:  Cancer Res       Date:  1991-07-01       Impact factor: 12.701

7.  Specific killing of human T-leukemia cells by immunotoxins prepared with ricin A chain and monoclonal anti-human T-cell leukemia antibodies.

Authors:  B K Seon
Journal:  Cancer Res       Date:  1984-01       Impact factor: 12.701

8.  Listeriolysin O as cytotoxic component of an immunotoxin.

Authors:  Sabine Bergelt; Stefan Frost; Hauke Lilie
Journal:  Protein Sci       Date:  2009-06       Impact factor: 6.725

9.  Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes.

Authors:  Masanori Onda; Richard Beers; Laiman Xiang; Byungkook Lee; John E Weldon; Robert J Kreitman; Ira Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-21       Impact factor: 12.779

10.  Retinoic acid disrupts the Golgi apparatus and increases the cytosolic routing of specific protein toxins.

Authors:  Y N Wu; M Gadina; J H Tao-Cheng; R J Youle
Journal:  J Cell Biol       Date:  1994-05       Impact factor: 10.539

View more
  13 in total

Review 1.  Getting across the cell membrane: an overview for small molecules, peptides, and proteins.

Authors:  Nicole J Yang; Marlon J Hinner
Journal:  Methods Mol Biol       Date:  2015

2.  Antibody-mediated neutralization of perfringolysin o for intracellular protein delivery.

Authors:  Nicole J Yang; David V Liu; Demetra Sklaviadis; Dan Y Gui; Matthew G Vander Heiden; K Dane Wittrup
Journal:  Mol Pharm       Date:  2015-05-04       Impact factor: 4.939

3.  Recombinant TAT-gelonin fusion toxin: synthesis and characterization of heparin/protamine-regulated cell transduction.

Authors:  Meong Cheol Shin; Jingwen Zhao; Jian Zhang; Yongzhuo Huang; Huining He; Mei Wang; Kyoung Ah Min; Victor C Yang
Journal:  J Biomed Mater Res A       Date:  2014-04-23       Impact factor: 4.396

4.  Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy.

Authors:  Joseph Ryan Polli; Ping Chen; Brandon M Bordeau; Joseph P Balthasar
Journal:  AAPS J       Date:  2022-03-25       Impact factor: 3.603

Review 5.  Anti-tumor activities and apoptotic mechanism of ribosome-inactivating proteins.

Authors:  Meiqi Zeng; Manyin Zheng; Desheng Lu; Jun Wang; Wenqi Jiang; Ou Sha
Journal:  Chin J Cancer       Date:  2015-07-17

Review 6.  Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy.

Authors:  Roger Gilabert-Oriol; Alexander Weng; Benedicta von Mallinckrodt; Matthias F Melzig; Hendrik Fuchs; Mayank Thakur
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Natural and Designed Toxins for Precise Therapy: Modern Approaches in Experimental Oncology.

Authors:  Olga Shilova; Elena Shramova; Galina Proshkina; Sergey Deyev
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

8.  A Nonpolycationic Fully Proteinaceous Multiagent System for Potent Targeted Delivery of siRNA.

Authors:  David V Liu; Nicole J Yang; K Dane Wittrup
Journal:  Mol Ther Nucleic Acids       Date:  2014-05-13       Impact factor: 10.183

Review 9.  Augmenting the Efficacy of Immunotoxins and Other Targeted Protein Toxins by Endosomal Escape Enhancers.

Authors:  Hendrik Fuchs; Alexander Weng; Roger Gilabert-Oriol
Journal:  Toxins (Basel)       Date:  2016-07-01       Impact factor: 4.546

Review 10.  The Use of Plant-Derived Ribosome Inactivating Proteins in Immunotoxin Development: Past, Present and Future Generations.

Authors:  Aleksander Rust; Lynda J Partridge; Bazbek Davletov; Guillaume M Hautbergue
Journal:  Toxins (Basel)       Date:  2017-10-27       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.